Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Adagene Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1.51
0.48
0.7
10.2
9.29
18.1
0.1
7.67
Research and development
16.1
16.2
33.5
68.1
81.3
36.6
28.8
22
General and administrative
2.77
3.44
10.3
14.4
11.9
8.67
7.27
7.08
Operating income
-17.3
-19.2
-43.2
-72.4
-83.9
-23.7
-36
-21.4
Interest expense
0.09
0.14
0.2
0.36
0.69
1.11
0.85
0.46
Interest income
0.38
4.28
3.8
2.3
Pre-tax income
-15.3
-16.4
-42.4
-71.5
-79.5
-17.3
-33.4
-17.9
Income tax
1.7
0.46
1.69
-0.02
-0.3
Net income
-15.3
-16.4
-42.4
-73.2
-80
-18.9
-33.4
-17.6
EBITDA
-16.4
-18.4
-42.3
-71.2
-82.8
-22.7
-35.2
-21
EPS, basic
-0.94
-1.10
-2.67
-1.46
-1.48
-0.35
-0.59
-0.30
EPS, diluted
-0.94
-1.10
-2.67
-1.46
-1.48
-0.35
-0.59
-0.30
Shares, basic (weighted)
15.2
15.2
16
50
54.1
54.7
56.3
59
Shares, diluted (weighted)
15.2
15.2
16
50
54.1
54.7
56.3
59
Balance sheet
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
16.1
92.5
75.2
174
144
110
85.2
74.5
Short-term investments
8
0
0
0
Receivables
0.48
3
Other current assets
0.07
0.26
0.62
0.8
0.91
0.53
1.2
Total current assets
104
79.1
186
149
113
87.8
77.4
Property, plant and equipment
1.88
2.07
3.49
2.78
1.84
1.13
0.72
Lease right-of-use assets
0.19
0.37
0.28
0.15
Other non-current assets
0.09
3.1
0.07
0.11
0.08
0.08
0.03
Total assets
106
84.3
190
152
116
89.3
78.3
Accounts payable
0.71
1.81
3.32
3.67
3.09
4.24
2.88
Accrued liabilities
2.37
2.39
3.23
1.1
1.18
1.1
1.25
Deferred revenue
0.99
0.73
5.5
15.1
3.46
Short-term debt
1.04
5.02
4.5
13.6
8.4
17.8
4.98
Total current liabilities
7.18
16.1
29.8
55.1
31.5
38.2
25.2
Long-term debt
1.52
2.97
2.99
14.1
13.5
0.42
1.14
Lease liabilities
0.05
0.17
0.14
0.05
Other non-current liabilities
0.09
0.09
0.03
Total liabilities
8.7
19.2
33
69.3
45.2
38.7
26.4
Total debt
1.84
4.15
4.37
17
17.7
13.3
1.85
Paid-in capital
6.79
23.8
336
343
350
362
366
Retained earnings
-63.3
-106
-179
-259
-278
-311
-329
Treasury stock
-0.62
-0
-0
Other comprehensive income
-0.34
-0.35
-0.09
-0.85
-1.8
-0.53
-1.91
Shareholders' equity
-41
-57
-89.4
157
83.1
70.6
50.5
35.3
Total equity
-41
-57
-89.4
157
83.1
70.6
50.5
35.3
Total liabilities and equity
106
84.3
190
152
116
89.3
78.3
Shares outstanding
15.2
16.6
54.6
54.1
55.1
58.9
59.2
Cash flow statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-15.3
-16.4
-42.4
-73.2
-80
-18.9
-33.4
-17.6
Depreciation and amortization
0.91
0.82
0.86
1.13
1.15
0.98
0.72
0.44
Stock-based compensation
0.13
0.61
10.1
18.7
10.5
7.27
4.91
3.74
Deferred income tax
0.04
-0.04
Change in receivables
-0.48
0.48
-3
3
Change in payables
0.39
0.15
1.1
1.51
0.34
-0.57
1.15
-1.36
Cash from operations
-14.3
-18.2
-28.5
-43.4
-48.6
-28.5
-29.7
-15.7
Capital expenditures
-0.51
-0.15
-0.94
-2.51
-0.69
-0.09
-0.03
-0.02
Purchases of investments
-58
-19
-47
-129
-80
Cash from investing
-29.5
24.9
7.07
-2.51
-0.69
-0.08
1.11
0.48
Debt issued
2.42
2.65
6.08
4.39
25.8
8.13
4.92
5.64
Debt repaid
-1.36
-2.42
-1.06
-5.09
-4.35
-13.5
-8.34
-17.9
Stock issued
0.46
0.14
0.23
0.32
0.01
7.33
0.14
Share buybacks
-2.36
-3.98
Cash from financing
51.1
69.7
4.44
145
17.8
-5.37
3.77
4.45
Net change in cash
7.32
76.5
-17.4
99.2
-30.6
-33.8
-24.7
-10.7
Free cash flow
-14.8
-18.3
-29.5
-45.9
-49.3
-28.5
-29.7
-15.7
Interest paid
0.09
0.14
0.2
0.36
0.6
1.05
0.78
0.4
Income taxes paid
2.43
1.38
0.03
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.93 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-279.5%
Operating income / revenue.
EBITDA margin
-273.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-233.4%
Pre-tax income / revenue.
Net margin
-229.6%
Net income / revenue.
FCF margin
-204.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-204.1%
Cash from operations / revenue.
Return on equity (ROE)
-41.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-21.0%
Net income / average total assets.
R&D / revenue
287.2%
Research and development expense / revenue.
Stock-based pay / revenue
48.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.2%
Capital expenditures / revenue.
D&A / revenue
5.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
7,333.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-6.2%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
61.4%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-30.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-24.8%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-12.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-19.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-1.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
4.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
2.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
29.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.07x
Current assets / current liabilities.
Quick ratio
2.96x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.96x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.05x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
2.4%
Total debt / total assets.
Liabilities / assets
33.7%
Total liabilities / total assets.
Net debt
-$72.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.30
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.13
Revenue / diluted weighted shares.
FCF per share
-$0.27
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.27
Cash from operations / diluted weighted shares.
Book value per share
$0.60
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
25.2x
Market cap / revenue.
P/B
5.47x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
5.47x
Market cap / tangible book value, when positive.
EV/Sales
15.8x
Enterprise value / revenue.
FCF yield
-8.1%
Free cash flow / market cap.
Earnings yield
-9.1%
Net income / market cap (the inverse of P/E).
What was Adagene Inc.'s revenue in fiscal 2025?
Adagene Inc. reported revenue of $7.7M for fiscal 2025, 7,332.8% higher than the year before.
Was Adagene Inc. profitable in fiscal 2025?
No. It reported a net loss of $17.6M.
How much free cash flow did Adagene Inc. generate in fiscal 2025?
Cash from operations of $15.7M minus capital expenditures of $17.1K left free cash flow of -$15.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.